v3.25.2
Consolidated Statement of Cash Flows
$ in Thousands
 9 Months Ended
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Operating activities:    
Net increase (decrease) in net assets resulting from operations $ 9,342 $ 20,992
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net unrealized (appreciation) depreciation 83,065 24,078
Net realized (gains) losses 24,037 84,508
PIK interest income (15,329) (14,814)
Accretion of original issue discount on investments (13,496) (12,017)
Accretion of original issue discount on unsecured notes payable 804 978
Amortization of deferred financing costs 7,700 3,762
Deferred taxes 269 (5)
Purchases of investments (739,370) (1,025,659)
Proceeds from the sales and repayments of investments 871,828 723,758
Changes in operating assets and liabilities:    
(Increase) decrease in interest, dividends and fees receivable 15,594 12,518
(Increase) decrease in due from portfolio companies 12,233 5,363
(Increase) decrease in receivables from unsettled transactions 6,579 36,681
(Increase) decrease in due from broker 1,510 23,950
(Increase) decrease in other assets (5,810) (918)
Increase (decrease) in accounts payable, accrued expenses and other liabilities (2,646) 120
Increase (decrease) in base management fee and incentive fee payable (7,914) (4,132)
Increase (decrease) in due to affiliate (1,707) 493
Increase (decrease) in interest payable (3,985) 3,322
Increase (decrease) in payables from unsettled transactions (15,666) 40,589
Net cash provided by (used in) operating activities 227,038 (76,433)
Financing activities:    
Distributions paid in cash (114,136) (133,130)
Borrowings under credit facilities 405,000 205,000
Repayments of borrowings under credit facilities (605,000) (125,000)
Repayments of unsecured notes (300,000) 0
Issuance of unsecured notes 299,976 0
Shares issued under the "at the market" offering 2,960 92,748
Repurchases of common stock under dividend reinvestment plan (9,495) 0
Shares issued in private placement 100,000 0
Deferred financing costs paid (8,377) (1,039)
Deferred offering costs paid (43) (117)
Net cash provided by (used in) financing activities (229,115) 38,462
Effect of exchange rate changes on foreign currency 3,333 (254)
Net increase (decrease) in cash and cash equivalents and restricted cash 1,256 (38,225)
Cash and cash equivalents and restricted cash, beginning of period 78,543 145,539
Cash and cash equivalents and restricted cash, end of period 79,799 107,314
Supplemental information:    
Cash paid for interest 85,295 88,502
Non-cash financing activities:    
Issuance of shares of common stock under dividend reinvestment plan 0 5,662
Deferred financing costs 45 $ 1,000
Reconciliation to the Consolidated Statements of Assets and Liabilities    
Cash and cash equivalents 79,799  
Restricted cash 0  
Total cash and cash equivalents and restricted cash $ 79,799